Open Access Article
International Journal of Medicine and Data. 2026; 10: (1) ; 107-109 ; DOI: 10.12208/j.ijmd.20260026.
Research on factors affecting errors and preventive measures in microbial limit testing of pharmaceuticals
药品微生物限度检验误差影响因素及防范措施研究
作者:
王福常 *,
王丽华
临沂市兰山区市场监督管理局 山东临沂
*通讯作者:
王福常,单位:临沂市兰山区市场监督管理局 山东临沂; ;
发布时间: 2026-03-31 总浏览量: 55
PDF 全文下载
引用本文
摘要
药品微生物限度检验是药品质量把控的核心环节之一,其检验结果精准度,直接关联药品安全度、有效性以及临床用药风险防范与控制,鉴于检验流程囊括样品处理、实验环境、操作流程、仪器设备等多个环节,易受到多种因素干扰而出现检验误差,对药品质量评估的科学性与可靠性产生影响。本文结合近年来药品微生物限度检验领域的研究进展,系统解析导致检验误差的主要影响因素,如人员操作、仪器设备、实验材料、检验方法、环境条件等方面,针对性给出对应的防范举措,旨在规范检验操作流程、降低检验误差、提升检验结果精准性,为药品微生物限度检验工作规范化开展给予理论参考以及实践指引。
关键词: 药品;微生物限度检验;误差;影响因素;防范措施
Abstract
Microbial limit testing of pharmaceuticals is one of the core aspects of pharmaceutical quality control. The accuracy of its test results is directly related to drug safety, efficacy, and the prevention and control of clinical medication risks. As the testing process involves multiple stages, such as sample processing, experimental environment, operational procedures, and instrument and equipment usage, it is susceptible to various interfering factors that may lead to testing errors, thereby affecting the scientific validity and reliability of drug quality evaluation. Based on recent research advances in the field of pharmaceutical microbial limit testing, this paper systematically analyzes the main factors influencing testing errors, including personnel operation, instruments and equipment, experimental materials, testing methods, and environmental conditions. Corresponding preventive measures are proposed accordingly, aiming to standardize testing procedures, reduce testing errors, and enhance the accuracy of test results. This study provides theoretical reference and practical guidance for the standardized implementation of pharmaceutical microbial limit testing.
Key words: Pharmaceuticals; Microbial limit testing; Errors; Influencing factors; Preventive measures
参考文献 References
[1] 王似锦,马仕洪. 良好药品微生物实验室系统的设计、建设与质量管理[J]. 中国药品标准,2023,24(6):591-595.
[2] 贾春燕. 质量标准中微生物限度检查教学模式的探讨[J]. 新疆中医药,2024,42(5):93-96.
[3] 曹鲁娜,毕言锋,任仲丽,等. 探讨药品微生物限度检查中的误差影响因素及改进措施[J]. 中国检验检测,2022, 30(4):60-63.
[4] 黄韵璇,陈伟盛. 国家药品抽检中妇康片的微生物限度检查及超标原因分析[J]. 今日药学,2025,35(3):191-195.
[5] 黄韵璇,朱晓燕,高颖,等. 药品微生物检验环境菌库建立实践[J]. 中国药业,2025,34(12):76-80.
[6] 陈晓双,刘义,宋毅,等. 多方法结合建立不同剂型医院外用制剂的微生物限度方法学及适用性评价[J]. 安徽医药,2025,29(4):840-844.
[7] 王杠杠,王似锦,马仕洪. 非无菌原料药微生物限度检验量酌减的风险评估方法探讨[J]. 中国药事,2025,39(7): 795-800.
[8] 严筱楠,高霞,高娟,等. 8种医院制剂微生物限度检查法的适用性试验[J]. 实验室检测,2025,3(1):74-77.
引用本文
王福常, 王丽华, 药品微生物限度检验误差影响因素及防范措施研究[J]. 国际医学与数据杂志, 2026; 10: (1) : 107-109.